Showing results (1201-1210 of 1,308) with videos related to

Sort By:
Pageof 131
Movement Disorders : Official Journal of the Movement Disorder Society|November 6, 2012
Seizures in juvenile Huntington's disease: frequency and characterization in a multicenter cohortLeslie J Cloud, Adam Rosenblatt, Russel L Margolis, et al.
The Pharmacogenomics Journal|October 4, 2012
A genetic basis for the variable effect of smoking/nicotine on Parkinson's diseaseE M Hill-Burns, N Singh, P Ganguly, et al.
Nature Communications|January 10, 2019
The mitochondrial type IB topoisomerase drives mitochondrial translation and carcinogenesisS A Baechler, V M Factor, I Dalla Rosa, et al.
Bioengineering & Translational Medicine|January 26, 2022
Transplantation of patient-specific bile duct bioengineered with chemically reprogrammed and microtopographically differentiated cellsElina Maria Buisson, Suk-Hee Park, Myounghoi Kim, et al.
The American Journal of Pathology|January 17, 2013
Alterations in glucose homeostasis in a murine model of Chagas diseaseFnu Nagajyothi, Regina Kuliawat, Christine M Kusminski, et al.
Movement Disorders Clinical Practice|March 23, 2023
Patients with Cognitive Impairment in Parkinson's Disease Benefit from Deep Brain Stimulation: A Case-Control StudyCady K Block, Margi Patel, Benjamin B Risk, et al.
Neurobiology of Disease|January 26, 2010
Occupational exposure to PCBs reduces striatal dopamine transporter densities only in women: a beta-CIT imaging studyRichard F Seegal, Kenneth L Marek, John P Seibyl, et al.
American Journal of Physiology. Cell Physiology|October 22, 2002
Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblastsAlex W Cohen, David S Park, Scott E Woodman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2020
Serum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract CancersDan Høgdall, Colm J O'Rourke, Christian Dehlendorff, et al.
Stem Cell Reports|August 28, 2018
Chemical Screening Identifies Enhancers of Mutant Oligodendrocyte Survival and Unmasks a Distinct Pathological Phase in Pelizaeus-Merzbacher DiseaseMatthew S Elitt, H Elizabeth Shick, Mayur Madhavan, et al.
Pageof 131